Deborah A. Eppstein

President, Chief Executive Officer & Director at Q Therapeutic Products, Inc.

Deborah A. Eppstein

Deborah A. Eppstein

President, Chief Executive Officer & Director at Q Therapeutic Products, Inc.

Overview
Career Highlights

Q Therapeutic Products, Inc.
Q Therapeutics, Inc.
Q Therapeutics, Inc.

RelSci Relationships

80

Number of Boards

3

Birthday

1949

Age

69

Relationships

Professor at Harvard University

Advisor at Kickstart Seed Fund LP

Co-Founder at Toucan Capital Corp.

President & Founder at P.E. Grebow Consulting, Inc.

Chief Scientific Officer at Complexa, Inc.

Chief Executive Officer at Systemix, Inc.

President, Chief Executive Officer & Chairman of the Board of Directors at Q Therapeutics, Inc.

Scientific Co-Founder at Q Therapeutics, Inc.

Vice President-Research & Development at Q Therapeutic Products, Inc.

Former Vice President & General Manager-Primary & STEM Systems Group at Life Technologies Corp.

Subscribe to RelSci Professional to see 80 more Relationships
Paths to Deborah A. Eppstein
Potential Connections via
Relationship Science
You
Deborah A. Eppstein
President, Chief Executive Officer & Director at Q Therapeutic Products, Inc.
Education

Grinnell College is a private liberal arts college in Grinnell, Iowa, U.S. known for its rigorous academics and tradition of social responsibility. It was founded in 1846, when a group of New England Congregationalists established the Trustees of Iowa College. Grinnell College is located in the town of Grinnell, Iowa, about halfway between Des Moines and Iowa City. The main campus is bounded by 6th Avenue (which is also Highway 6) on the south, 10th Avenue on the north, East Street on the east and Park Street on the west. The 120-acre (0.49 km2) campus contains sixty-three buildings ranging in style from Collegiate Gothic to Bauhaus.

The University of Arkansas was founded in 1871 as a land-grant institution, and is the flagship of the University of Arkansas System. The U of A has 10 colleges and schools offering more than 210 academic programs. The University of Arkansas is accredited by the Higher Learning Commission. Their picturesque campus is located in Fayetteville in the hilly northwest corner of Arkansas and includes two arboreta overlooking the Ozark Mountains. Some of the nation’s best outdoor amenities and most spectacular hiking trails are within a short drive of campus. Fayetteville is routinely considered among the country’s finest college towns, and the surrounding Northwest Arkansas region is regularly ranked one of the best places to live in the U.S.

Career History
President, Chief Executive Officer & Director
2006 - Current

Q Therapeutic Products, Inc. develops novel products to treat debilitating and fatal diseases. The company was founded by Dennis B. Farrar and Mahendra S. Rao in 2004 and is headquartered in Salt Lake, UT.

President, Chief Executive Officer & Director
2006 - Current
President, Chief Executive Officer & Director
2006 - Prior

Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT.

Subscribe now for extended career history
Boards & Committees
President, Chief Executive Officer & Director
2006 - Current

Q Therapeutic Products, Inc. develops novel products to treat debilitating and fatal diseases. The company was founded by Dennis B. Farrar and Mahendra S. Rao in 2004 and is headquartered in Salt Lake, UT.

President, Chief Executive Officer & Director
2006 - Current
President, Chief Executive Officer & Director
2006 - Prior

Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT.

Subscribe now to see 1 more corporate board memberships
Subscribe now to see non-profit board memberships for over 7 million people
Subscribe now to see government board memberships for over 7 million people
Transactions
Details Hidden

Q Therapeutics, Inc. raised money in a private placement transaction

Investments
Details Hidden

Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT.

Details Hidden

Altea Therapeutics Corp. develops pharmaceutical products. It offers PassPort patch, a skin patch that uses short bursts of focused thermal energy to create tiny channels in the surface of the skin and these channels permit the flow of proteins, peptides, carbohydrates, and small molecules into the body without the use of needles. The firm also provides Transdermal vaccine patch, a delivery system for water-soluble drugs and proteins; disease prevention products; insulin skin patch, a non-injectable daily insulin product; and opioid patches that provide delivery of opioids and incorporates the layers of deterrents. The company was founded by Jonathan A Eppstein and Deborah Eppstein in 1998 and is headquartered in Atlanta, GA.

Subscribe now to see investments for over 7 million people